Intravitreal triamcinolone acetonide in the treatment of macular retinal detachment associated with morning glory anomaly.
OBJECTIVE
To report the successful treatment of a case of recurrent macular retinal detachment associated with morning glory anomaly using intravitreal triamcinolone acetonide.


METHODS
A 53-year-old man with a history of bilateral morning glory anomaly and recurrent macular detachment of the left eye refractory to multiple surgical interventions, including 3 vitrectomies with endolaser photocoagulation, gas tamponade, and fibrin glue, underwent an intravitreal injection of 4 mg triamcinolone acetonide.


RESULTS
A single treatment with intravitreal triamcinolone acetonide resulted in resolution of a macular retinal detachment and intraretinal fluid within 2 weeks.


CONCLUSIONS
Treatment with intravitreal triamcinolone acetonide may be beneficial in cases of macular retinal detachment associated with morning glory anomaly.
From the *Vitreoretinal Service, Duke Eye Center, Durham, North Carolina; †Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania; and ‡Ophthalmology Associates, Louisville, Kentucky.
Annie C
AC
Lee
Julia A
JA
Haller
Kenneth R
KR
Jaegers
Brooks W
BW
McCuen